Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00415389 · ClinicalTrials.gov registry record · Phase 2

The Stroke Warning Information and Faster Treatment Study (SWIFT)

A Phase 2 study, sponsored by Columbia University.

Terminated
Registry status
Phase 2
Development phase
1,635
Enrollment target

NCT00415389: Clinical Trial Phase 2 study, sponsored by Columbia University.

NCT00415389 is a Phase 2 study that was terminated before completion, run by Columbia University. The registered enrollment target is 1,635 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1129% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00415389, a Phase 2 study, was terminated before completion, sponsored by Columbia University.

TERMINATED
Registry status
Phase 2
Development phase
1,635 participants
Enrollment target

Study Summary

The purposes of this study are to determine the effectiveness of an interactive stroke educational program compared to standard educational materials and usual care, to increase stroke knowledge, and to improve emergency room arrival times upon onset of stroke symptoms.

Interventions

  • BEHAVIORAL interactive educational program
  • BEHAVIORAL usual medical care

Trial Details

FieldValue
Enrollment Target 1,635 participants
Start Date 2005-02
Est. Completion 2012-10
Phase Phase 2
Columbia University

958 total trials

Why NCT00415389 stopped before completion

NCT00415389 is an interventional study that assigns participants to a tested intervention. Its 1,635 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1129% higher).

The record links to 0 conditions, and to 2 interventions - of which interactive educational program is the first listed.

NCT00415389 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00415389 about?

NCT00415389 is a clinical study titled "The Stroke Warning Information and Faster Treatment Study (SWIFT)". The purposes of this study are to determine the effectiveness of an interactive stroke educational program compared to standard educational materials and usual care, to increase stroke knowledge, and to improve emergency room arrival times upon onset of stroke symptoms.

What is the current status of trial NCT00415389?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1,635 participants. The study started on 2005-02. Estimated completion is 2012-10.

What interventions are being tested in trial NCT00415389?

The interventions under investigation include: interactive educational program (BEHAVIORAL), usual medical care (BEHAVIORAL).

Who is sponsoring clinical trial NCT00415389?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00415389's enrollment target sits among peer trials

1,635 11th of 2000 higher than 1,990 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04510129 · 1,650 participants

    A Multicenter Cancer Biospecimen Collection Study

  • NCT05612750 · 1,650 participants · NA

    Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study

  • NCT06215716 · 1,650 participants · Phase 3

    A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

  • NCT07046260 · 1,650 participants

    Prospective Study to Assess a Diagnostic Aid for Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00415389, the US trial registry maintained by the National Library of Medicine. NCT00415389 (large enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.